南模生物
(688265)
| 流通市值：32.28亿 | | | 总市值：32.28亿 |
| 流通股本：7796.35万 | | | 总股本：7796.35万 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 318,727,024.99 | 150,389,759.96 | 123,995,787.94 | 183,237,020.5 |
| 交易性金融资产 | 613,262,548.04 | 883,150,716.98 | 863,193,541.65 | 823,187,204.09 |
| 应收票据及应收账款 | 133,104,997.47 | 112,428,793.97 | 132,021,540.44 | 127,541,453.91 |
| 其中：应收票据 | 50,000 | 50,000 | 129,550 | 37,550 |
| 应收账款 | 133,054,997.47 | 112,378,793.97 | 131,891,990.44 | 127,503,903.91 |
| 预付款项 | 4,043,909.9 | 3,657,966.31 | 3,587,678.28 | 3,098,220.59 |
| 其他应收款合计 | 2,919,234.17 | 3,036,323.18 | 1,595,280.47 | 1,613,474.41 |
| 存货 | 26,764,624.3 | 18,715,576.98 | 17,779,992.92 | 15,419,869.61 |
| 其他流动资产 | 11,745,780.03 | 9,856,985.43 | 8,294,722.18 | 7,504,336.48 |
| 流动资产合计 | 1,110,568,118.9 | 1,181,236,122.81 | 1,150,468,543.88 | 1,161,601,579.59 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 125,296,400.74 | 83,296,400.74 | 80,106,335.29 | 59,006,335.29 |
| 固定资产 | 241,825,513.56 | 245,280,628.79 | 244,526,365.17 | 250,427,389.75 |
| 在建工程 | 125,449,373.36 | 110,700,749.63 | 81,134,436.88 | 68,996,225.89 |
| 使用权资产 | 48,968,510.12 | 47,329,131.55 | 31,591,002.42 | 52,852,215.09 |
| 无形资产 | 233,551,803.26 | 235,372,706.02 | 236,735,574 | 238,624,786.63 |
| 长期待摊费用 | 49,255,876.68 | 44,343,538.35 | 47,518,858.81 | 50,769,145.35 |
| 递延所得税资产 | 29,409,662.39 | 28,670,102.9 | 26,363,109.04 | 25,952,705.2 |
| 其他非流动资产 | 1,417,259.73 | 7,293,674.74 | 770,313.71 | 692,170.7 |
| 非流动资产合计 | 855,174,399.84 | 802,286,932.72 | 748,745,995.32 | 747,320,973.9 |
| 资产总计 | 1,965,742,518.74 | 1,983,523,055.53 | 1,899,214,539.2 | 1,908,922,553.49 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 55,660,190.63 | 61,283,756.35 | 29,376,708.73 | 24,994,166.32 |
| 其中：应付票据 | 6,000,000 | - | - | - |
| 应付账款 | 49,660,190.63 | 61,283,756.35 | 29,376,708.73 | 24,994,166.32 |
| 预收款项 | 90,900.85 | 192,147.01 | 510,270.82 | 364,200.93 |
| 合同负债 | 97,034,615.16 | 102,072,465.05 | 86,774,432.83 | 81,462,215.91 |
| 应付职工薪酬 | 18,617,700.47 | 32,731,605.32 | 17,558,117.04 | 21,696,867.77 |
| 应交税费 | 681,063.25 | 1,582,362.46 | 1,671,854.57 | 1,121,710.11 |
| 其他应付款合计 | 1,875,192.76 | 2,370,481.25 | 1,952,224.27 | 1,766,896.88 |
| 一年内到期的非流动负债 | 16,398,132.24 | 15,735,929.45 | 16,201,439.31 | 23,930,424 |
| 流动负债合计 | 190,357,795.36 | 215,968,746.89 | 154,045,047.57 | 155,336,481.92 |
| 非流动负债: | | | | |
| 租赁负债 | 42,599,371.09 | 41,078,506.41 | 25,008,665.93 | 42,610,592.72 |
| 递延收益 | 19,097,266.57 | 16,256,502.18 | 16,996,244.78 | 18,098,817.01 |
| 递延所得税负债 | 934,674.65 | 1,030,989.78 | 1,074,586.07 | 1,111,729.38 |
| 非流动负债合计 | 62,631,312.31 | 58,365,998.37 | 43,079,496.78 | 61,821,139.11 |
| 负债合计 | 252,989,107.67 | 274,334,745.26 | 197,124,544.35 | 217,157,621.03 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 77,963,513 | 77,963,513 | 77,963,513 | 77,963,513 |
| 资本公积 | 1,563,204,977.35 | 1,560,340,713.07 | 1,557,791,491.01 | 1,555,971,728.51 |
| 减:库存股 | 62,086,095.9 | 62,086,095.9 | 62,086,095.9 | 62,086,095.9 |
| 其他综合收益 | 130,869.88 | 113,668.94 | 236,200.23 | 328,430.45 |
| 盈余公积 | 24,081,471.39 | 24,081,471.39 | 20,162,524.6 | 20,162,524.6 |
| 未分配利润 | 109,458,675.35 | 108,775,039.77 | 108,022,361.91 | 99,424,831.8 |
| 归属于母公司股东权益合计 | 1,712,753,411.07 | 1,709,188,310.27 | 1,702,089,994.85 | 1,691,764,932.46 |
| 股东权益合计 | 1,712,753,411.07 | 1,709,188,310.27 | 1,702,089,994.85 | 1,691,764,932.46 |
| 负债和股东权益合计 | 1,965,742,518.74 | 1,983,523,055.53 | 1,899,214,539.2 | 1,908,922,553.49 |
| 公告日期 | 2026-04-30 | 2026-04-27 | 2025-10-30 | 2025-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |